Moreover, relative to tumor-free survival patients, tumor-bearing patients significantly expressed high levels of SKA1 and SKA3 (Figure 7J) and both of them did not corelate with advanced pathological T (T3/4) (Figure 7K). This evidence concerns the gene SKA1 and neoplasm.